CNSX:EHC

Stock Analysis Report

Executive Summary

Eviana Health Corporation produces and sells cannabinoid products from natural hemp strains of cannabis sativa for medical, beauty and grooming, vitamins and supplements, fitness, food and beverage, and pet markets.

Snowflake

Fundamentals

Adequate balance sheet and overvalued.

Risks

  • Eviana Health is not covered by any analysts.

Share Price & News

How has Eviana Health's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-25.5%

CNSX:EHC

0.7%

CA Chemicals

1.6%

CA Market


1 Year Return

-87.2%

CNSX:EHC

-15.3%

CA Chemicals

-0.5%

CA Market

EHC underperformed the Chemicals industry which returned -15.4% over the past year.

EHC underperformed the Market in Canada which returned -0.3% over the past year.


Share holder returns

EHCIndustryMarket
7 Day-25.5%0.7%1.6%
30 Day-43.8%5.0%3.9%
90 Day-48.8%-5.5%0.8%
1 Year-87.2%-87.2%-12.7%-15.3%3.0%-0.5%
3 Yearn/a19.8%13.1%19.5%8.8%
5 Yearn/a-27.7%-35.0%21.0%3.6%

Price Volatility Vs. Market

How volatile is Eviana Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Eviana Health undervalued based on future cash flows and its price relative to the stock market?

1.04x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Eviana Health to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Eviana Health to establish if it is available at substantial discount.


Price Based on Earnings

Eviana Health is loss making, we can't compare its value to the CA Chemicals industry average.

Eviana Health is loss making, we can't compare the value of its earnings to the Canada market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Eviana Health, we can't assess if its growth is good value.


Price Based on Value of Assets

Eviana Health is good value based on assets compared to the CA Chemicals industry average.


Next Steps

Future Growth

How is Eviana Health expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

15.6%

Forecasted Materials industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Eviana Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Eviana Health performed over the past 5 years?

-47.1%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Eviana Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Eviana Health's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Eviana Health's 1-year growth to the CA Chemicals industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Eviana Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Eviana Health has efficiently used its assets last year compared to the CA Chemicals industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Eviana Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Eviana Health's financial position?


Financial Position Analysis

Eviana Health is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Eviana Health's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Eviana Health's level of debt (170%) compared to net worth is high (greater than 40%).

Unable to establish if Eviana Health's debt level has increased without past 5-year debt data.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 1.4x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Eviana Health has sufficient cash runway for 1.2 years based on current free cash flow.

Eviana Health has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 85.4% each year.


Next Steps

Dividend

What is Eviana Health's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Eviana Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Eviana Health's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Eviana Health has not reported any payouts.

Unable to verify if Eviana Health's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Eviana Health has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Eviana Health's salary, the management and board of directors tenure and is there insider trading?

2.1yrs

Average board tenure


CEO

Avram Adizes 0

2.1yrs

Tenure

CA$120,000

Compensation

Dr. Avram Adizes, Ph.D., P.E., serves as the Chief Technology Officer of Phoenix Capital Partners Inc. Dr. Adizes is responsible for Technology assessment and evaluation. Dr. Adizes serves as Chairman and  ...


CEO Compensation Analysis

Avram's remuneration is about average for companies of similar size in Canada.

Insufficient data for Avram to compare compensation growth.


Board Age and Tenure

2.1yrs

Average Tenure

The average tenure for the Eviana Health board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

SellCA$7,50028 Jan 19
Olivier Robert Benloulou
EntityIndividual
Shares10,000
Max PriceCA$0.75
SellCA$55,93031 Oct 18
Olivier Robert Benloulou
EntityIndividual
Shares65,800
Max PriceCA$0.85

Ownership Breakdown


Management Team

  • Sydney, Syd Au

    CFO & Director

    • Tenure: 6.3yrs
    • Compensation: CA$60.00k
  • Avram Adizes

    Chairman of the Board & CEO

    • Tenure: 2.1yrs
    • Compensation: CA$120.00k
  • Patrick Brown

    Vice-President of Business Development & Corporate Communications

    • Tenure: 1.3yrs

Board Members

  • Paolo De Luca (46yo)

    Director

    • Tenure: 0.9yrs
  • Sydney, Syd Au

    CFO & Director

    • Tenure: 6.3yrs
    • Compensation: CA$60.00k
  • Avram Adizes

    Chairman of the Board & CEO

    • Tenure: 2.1yrs
    • Compensation: CA$120.00k
  • Joel Sherlock

    Member of Advisory Board

    • Tenure: 1.2yrs
  • Ljiljana Vujotic

    Director

    • Tenure: 2.1yrs
    • Compensation: CA$100.00k

Company Information

Eviana Health Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Eviana Health Corporation
  • Ticker: EHC
  • Exchange: CNSX
  • Founded: 2011
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: CA$4.899m
  • Shares outstanding: 23.90m
  • Website: https://eviana.ca

Location

  • Eviana Health Corporation
  • 5728 East Boulevard
  • Vancouver
  • British Columbia
  • V6M 4M4
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
EHCCNSX (Canadian National Stock Exchange)YesCommon SharesCACADSep 2017
EVNN.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDSep 2017
1CPDB (Deutsche Boerse AG)YesCommon SharesDEEURSep 2017

Biography

Eviana Health Corporation produces and sells cannabinoid products from natural hemp strains of cannabis sativa for medical, beauty and grooming, vitamins and supplements, fitness, food and beverage, and pe ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/17 00:49
End of Day Share Price2019/09/16 00:00
Earnings2019/03/31
Annual Earnings2018/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.